Clinical Trials Browser

Recurrence × Interleukin 1 Receptor Antagonist Protein × Clear all

NCT01624766 2021-02-25

Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers

Phase 1 Completed

Neoplasm Metastasis, Neoplasms, Recurrence